Current
41.8×
5-Year Average
30.1×
All-Time High
226.9×
All-Time Low
9.3×
P/E Ratio daily chart for CVS Health (CVS)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/E Ratio for CVS Health (CVS) from 2001 to 2025
| 2025 | $100.79B | $1.77B | 57.0× | +44.8× | |
| 2024 | $56.52B | $4.61B | 12.2× | +0.1× | |
| 2023 | $101.70B | $8.34B | 12.2× | -16.3× | |
| 2022 | $122.08B | $4.28B | 28.5× | +11.3× | |
| 2021 | $136.38B | $7.91B | 17.2× | +4.8× | |
| 2020 | $89.54B | $7.18B | 12.5× | -2.1× | |
| 2019 | $96.80B | $6.63B | 14.6× | — | |
| 2018 | $73.10B | −$594.00M | — | — | |
| 2017 | $73.52B | $6.62B | 11.1× | -4.7× | |
| 2016 | $83.96B | $5.32B | 15.8× | -4.9× | |
| 2015 | $108.23B | $5.24B | 20.7× | -2.7× | |
| 2014 | $108.64B | $4.64B | 23.4× | +4.8× | |
| 2013 | $85.31B | $4.59B | 18.6× | +3.1× | |
| 2012 | $60.00B | $3.88B | 15.5× | +0.2× | |
| 2011 | $52.97B | $3.46B | 15.3× | +1.5× | |
| 2010 | $47.36B | $3.43B | 13.8× | +1.7× | |
| 2009 | $44.64B | $3.69B | 12.1× | -0.8× | |
| 2008 | $41.35B | $3.21B | 12.9× | -8.8× | |
| 2007 | $57.27B | $2.64B | 21.7× | +3.1× | |
| 2006 | $25.49B | $1.37B | 18.6× | +1.0× | |
| 2005 | $21.52B | $1.22B | 17.6× | -2.4× | |
| 2004 | $18.36B | $918.80M | 20.0× | +2.5× | |
| 2003 | $14.85B | $847.30M | 17.5× | +3.8× | |
| 2002 | $9.81B | $716.60M | 13.7× | -13.9× | |
| 2001 | $11.39B | $413.10M | 27.6× | — |
- 202557.0×
- 202412.2×
- 202312.2×
- 202228.5×
- 202117.2×
- 202012.5×
- 201914.6×
- 2018—
- 201711.1×
- 201615.8×
- 201520.7×
- 201423.4×
- 201318.6×
- 201215.5×
- 201115.3×
- 201013.8×
- 200912.1×
- 200812.9×
- 200721.7×
- 200618.6×
- 200517.6×
- 200420.0×
- 200317.5×
- 200213.7×
- 200127.6×
About P/E Ratio at CVS Health (CVS)
CVS Health (CVS) P/E ratio is 41.8× as of June 5, 2026. The 5-year average is 30.1×. The sector median currently stands at 25.0×. The current ratio is at the 89th percentile of its own 10-year history.
CVS Health (CVS) historical P/E ratio has ranged from a low of 9.3× (2024) to a high of 226.9× (2026) in the available daily series.
The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.
CVS Health P/E Ratio by Year
CVS Health P/E Ratio 2025: 57.0×
CVS Health (CVS) P/E ratio in 2025 was 57.0×, expanded from 12.2× the prior year.
CVS Health P/E Ratio 2024: 12.2×
CVS Health (CVS) P/E ratio in 2024 was 12.2×, expanded from 12.2× the prior year.
CVS Health P/E Ratio 2023: 12.2×
CVS Health (CVS) P/E ratio in 2023 was 12.2×, contracted from 28.5× the prior year.
CVS Health P/E Ratio 2022: 28.5×
CVS Health (CVS) P/E ratio in 2022 was 28.5×, expanded from 17.2× the prior year.
CVS Health P/E Ratio 2021: 17.2×
CVS Health (CVS) P/E ratio in 2021 was 17.2×.
Sector peers by P/E Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/E Ratio — table
Healthcare peers of CVS Health (CVS), ranked by P/E ratio.
| 22.2× | |
| 22.2× | |
| 21.7× | |
| 21.6× | |
| 21.6× | |
| 21.1× | |
| 21.1× | |
| 21.0× | |
| 20.9× | |
| 20.7× | |
| 20.4× | |
| 19.7× | |
| 18.9× | |
| 18.8× | |
| 18.5× | |
| 18.2× | |
| 17.0× | |
| 15.8× | |
| 13.3× | |
| 13.1× | |
| 12.3× | |
| 11.1× | |
| 8.6× | |
| 7.9× | |
| 7.2× |
- 22.2×
- 22.2×
- 21.7×
- 21.6×
- 21.6×
- 21.1×
- 21.0×
- 20.9×
- 20.7×
- 19.7×
- 18.9×
- 18.5×
- 15.8×
- 13.3×
- 13.1×
- 11.1×
- 7.9×
Frequently asked questions
CVS Health (CVS) Key Financials
Charts, filings, and peer comparison for every metric